1832 Asset Management L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
1832 Asset Management L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$628,989
-6.4%
6,518
-2.2%
0.00%0.0%
Q2 2023$672,262
-34.5%
6,662
-40.3%
0.00%0.0%
Q1 2023$1,026,904
+5.4%
11,162
+4.0%
0.00%
-50.0%
Q4 2022$973,879
+7.7%
10,735
-9.8%
0.00%0.0%
Q3 2022$904,000
-12.8%
11,896
-3.0%
0.00%0.0%
Q2 2022$1,037,000
-9.0%
12,262
-6.9%
0.00%0.0%
Q1 2022$1,140,000
-1.2%
13,168
+1.5%
0.00%0.0%
Q4 2021$1,154,000
+10.7%
12,979
+2.5%
0.00%0.0%
Q3 2021$1,042,000
-14.7%
12,666
-5.4%
0.00%0.0%
Q2 2021$1,222,000
-6.4%
13,391
-16.8%
0.00%
-33.3%
Q1 2021$1,306,000
-12.9%
16,093
-4.3%
0.00%
-25.0%
Q4 2020$1,500,000
+19.1%
16,817
+8.1%
0.00%
+33.3%
Q3 2020$1,259,000
+14.6%
15,550
+13.2%
0.00%0.0%
Q2 2020$1,099,000
-79.1%
13,738
-78.9%
0.00%
-84.2%
Q1 2020$5,264,000
+441.0%
65,106
+476.0%
0.02%
+533.3%
Q4 2019$973,000
+130.6%
11,303
+133.6%
0.00%
+200.0%
Q3 2019$422,000
-12.1%
4,838
-8.0%
0.00%
-50.0%
Q2 2019$480,000
-12.6%
5,260
-8.4%
0.00%0.0%
Q1 2019$549,000
+16.6%
5,742
+4.8%
0.00%0.0%
Q4 2018$471,000
-4.1%
5,478
-3.7%
0.00%0.0%
Q3 2018$491,000
+24.0%
5,687
+15.9%
0.00%
+100.0%
Q2 2018$396,000
+6.7%
4,906
+6.7%
0.00%0.0%
Q1 2018$371,000
-22.9%
4,597
-20.1%
0.00%
-50.0%
Q4 2017$481,000
-81.7%
5,750
-81.2%
0.00%
-77.8%
Q3 2017$2,626,000
-76.2%
30,643
-76.8%
0.01%
-82.0%
Q2 2017$11,048,000
-22.4%
132,314
-30.9%
0.05%
-2.0%
Q1 2017$14,234,000
-93.4%
191,587
-94.4%
0.05%
-85.9%
Q4 2016$214,740,000
+489.7%
3,407,268
+639.1%
0.36%
+164.2%
Q3 2016$36,416,000
-1.8%
461,005
+3.1%
0.14%
-4.9%
Q2 2016$37,083,000
-2.0%
447,065
+30.9%
0.14%
+56.5%
Q1 2016$37,853,000
-42.4%
341,541
-54.4%
0.09%
-67.6%
Q4 2015$65,774,000
+26.9%
749,231
+33.2%
0.28%
+30.9%
Q3 2015$51,832,000
+7.9%
562,281
+14.8%
0.22%
+33.1%
Q2 2015$48,050,000
+27.7%
489,657
+28.6%
0.16%
+15.6%
Q1 2015$37,617,000
+6.6%
380,900
-0.1%
0.14%
+29.4%
Q4 2014$35,285,000
+0.1%
381,190
+1.9%
0.11%
-5.2%
Q3 2014$35,245,000
+82.2%
374,090
+75.2%
0.12%
+88.5%
Q2 2014$19,346,000
+214855.6%
213,550
+213450.0%
0.06%
Q1 2014$9,000
-99.6%
100
-99.6%
0.00%
-100.0%
Q4 2013$2,034,00025,2660.01%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders